The invention is concerned with use of the model organism C. elegans as a research tool to screen for compounds active in insulin signalling. In particular, the invention relates to improved screening methods based on release of C. elegans from the dauer larval state.

 
Web www.patentalert.com

< Pyridazine derivatives and their use as therapeutic agents

< Quinoline- and isoquinoline-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof

> Cycloalkyl-substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments

> Substituted amino carboxylic acids
~ 00213